Abstract
This study was to assess the impact of a community pharmacist-led brief intervention in patients suffering from coexisting diabetes mellitus and hypertension in relation to knowledge and medication adherence. The study utilized a prospective, randomized controlled pilot design. The study was conducted in Kongsberg, Norway at community pharmacies and findings of the study showed significant improvement in patient’s knowledge about their diseases and adherence to medication. The results of this study can help to affirm the role of community pharmacist as an integral member of primary care services to maximize the quality of care and to develop a framework for medication adherence for chronic diseases such as diabetes and hypertension that matches the specific needs of the population. The development and implementation of community pharmacist-led diabetes and hypertension intervention can provide basis for the stakeholders to further develop various community pharmacist-led public health policies and practice. Findings of this study can lead to reduced healthcare expenditures by optimizing medication use, preventing unnecessary care, and minimizing adverse drug events. These findings can provide policy changes, advocating for increased funding and support for expanded pharmacist services.
